Title: CDC Launches Program to Optimize Hospital Sepsis Programs, T2 Biosystems Urges Adoption of New Technologies
The U.S. Centers for Disease Control and Prevention (CDC) have received praise from T2 Biosystems for their new program aimed at enhancing hospital sepsis programs across the United States. The CDC’s Hospital Sepsis Program Core Elements, designed to implement, monitor, and improve sepsis programs, is expected to improve survival rates for patients affected by this life-threatening condition.
Sepsis, a major cause of death in hospitals, affects one in three individuals who pass away during their hospitalization. To combat this alarming statistic, the CDC’s program encompasses seven essential elements: Hospital Leadership Commitment, Accountability, Multi-Professional Expertise, Action, Tracking, Reporting, and Education.
Leading the fight against sepsis, T2 Biosystems offers a range of innovative products, including the T2Dx® Instrument, the T2Bacteria® Panel, and the T2Candida® Panel. These are the first and only FDA-cleared products capable of directly detecting sepsis-causing pathogens from whole blood within a few hours, eliminating the need for lengthy blood culture tests.
A recent meta-analysis comparing T2 Biosystems’ products to conventional blood culture-based protocols revealed that they identify sepsis-causing pathogens a remarkable 77 hours faster, enabling patients to receive targeted antimicrobial treatment 42 hours sooner. This rapid detection is crucial, as delayed targeted treatment is associated with increased mortality rates.
Sepsis is the leading cause of death in U.S. hospitals, claiming approximately 350,000 American lives each year. Moreover, the condition imposes a significant burden on the U.S. healthcare system, resulting in costs amounting to $62 billion annually. Furthermore, sepsis is a leading cause of re-hospitalization within 30 days of discharge.
T2 Biosystems applauds the CDC for addressing the sepsis crisis and advocates for the widespread adoption of new products and technologies, emphasizing the need to improve patient outcomes and reduce costs. By embracing innovative solutions like those offered by T2 Biosystems, hospitals can effectively combat sepsis, saving lives and resources within the healthcare system.
In conclusion, the CDC’s Hospital Sepsis Program Core Elements is a crucial step towards optimizing sepsis management in hospitals nationwide. The endorsement of T2 Biosystems and their revolutionary products underscores the importance of rapid detection and treatment, ultimately leading to improved patient outcomes and reduced healthcare costs.
“Social media scholar. Reader. Zombieaholic. Hardcore music maven. Web fanatic. Coffee practitioner. Explorer.”